Programme finder (2/3)

Assess your innovation's TRL

The table below will help you assessing the TRL of your innovation by providing examples of maturity level of various innovation per industry sector. Assess your TRL based on the examples below, and the go to the funding options that correspond to your innovation's TRL.

TRL1 - Basic principles observed

TRL2 - Technology concept formulated

TRL3 - Experimental proof of concept

TRL4 - Technology validated in a lab

TRL5 - Technology validated in a relevant environment (industrially relevant environment in the case of key enabling technologies)

TRL6 - Technology demonstrated in a relevant environment (industrially relevant environment in the case of key enabling technologies)

TRL7 - System prototype demonstration in an operational environment

TRL8 - System complete and qualified

TRL9 - Actual system proven in an operational environment (competitive manufacturing in the case of key enabling technologies, or in space)

Type of innovation	Readiness level
A product that is manufactured	Analytical studies on separate elements of the technology. Laboratory based trials that show the feasibility of the predictions.
An industrial process	Laboratory experiments are designed to verify that the conceptual process works as expected.
A software	Initial script & functions to solve the desired problem.
A medical device	Initial proof of concept demonstrated with a limited number of in vitro & in vivo trials including the expected device characteristics.
A drug	Initial proof of concept demonstrated with a limited number of in vitro & in vivo models.

Type of innovation	Readiness level
A product that is manufactured	Analytical studies on separate elements of the technology. Laboratory based trials that show the feasibility of the predictions.
An industrial process	Laboratory experiments are designed to verify that the conceptual process works as expected.
A software	Initial script & functions to solve the desired problem.
A medical device	Initial proof of concept demonstrated with a limited number of in vitro & in vivo trials including the expected device characteristics.
A drug	Initial proof of concept demonstrated with a limited number of in vitro & in vivo models.

Type of innovation	Readiness level
A product that is manufactured	Analytical studies on separate elements of the technology. Laboratory based trials that show the feasibility of the predictions.
An industrial process	Laboratory experiments are designed to verify that the conceptual process works as expected.
A software	Initial script & functions to solve the desired problem.
A medical device	Initial proof of concept demonstrated with a limited number of in vitro & in vivo trials including the expected device characteristics.
A drug	Initial proof of concept demonstrated with a limited number of in vitro & in vivo models.

Type of innovation	Readiness level
A product that is manufactured	Analytical studies on separate elements of the technology. Laboratory based trials that show the feasibility of the predictions.
An industrial process	Laboratory experiments are designed to verify that the conceptual process works as expected.
A software	Initial script & functions to solve the desired problem.
A medical device	Initial proof of concept demonstrated with a limited number of in vitro & in vivo trials including the expected device characteristics.
A drug	Initial proof of concept demonstrated with a limited number of in vitro & in vivo models.

Type of innovation	Readiness level
A product that is manufactured	Analytical studies on separate elements of the technology. Laboratory based trials that show the feasibility of the predictions.
An industrial process	Laboratory experiments are designed to verify that the conceptual process works as expected.
A software	Initial script & functions to solve the desired problem.
A medical device	Initial proof of concept demonstrated with a limited number of in vitro & in vivo trials including the expected device characteristics.
A drug	Initial proof of concept demonstrated with a limited number of in vitro & in vivo models.